5'prime single cell RNA sequencing on the RNA samples
Ended Awarded Last action
- Contract number
- 75N91023F00005
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,103
Award facts
- Contract value 100% obligated
- $24,102.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94588, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute issued a BPA call to 10X Genomics, Inc. for $24,102.75 on February 2, 2023. The call covers 5' prime single cell RNA sequencing services on RNA samples. Place of performance is Pleasanton, California. Work is scheduled to complete by February 28, 2023. The call was priced firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract 75N91023F00005?
75N91023F00005 was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on February 2, 2023.
How much is contract 75N91023F00005 worth?
The government has obligated $24,103 on 75N91023F00005.
Is contract 75N91023F00005 an order under another contract?
Yes. 75N91023F00005 is a BPA call under 75N98022A00032, a blanket purchase agreement.
Was contract 75N91023F00005 competed?
The extent of competition for 75N91023F00005 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award